Excess granulation tissue during etretinate therapy.
D005050:Etretinate / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006097:Granulation Tissue / Q000187:drug effects*; D006801:Humans; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy
D005050:Etretinate